Pharmacokinetic	pharmacokinetic	O	O	O	O
and	and	O	O	O	O
clinical	clinical	O	O	O	O
studies	studies	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
cimetidine-associated	cimetidine-associated	O	O	O	O
mental	mental	O	O	O	O
confusion.15	confusion.15	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
cimetidine-associated	cimetidine-associated	O	O	O	O
mental	mental	O	O	O	O
confusion	confusion	O	DISEASE	OTHERS	I
have	have	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
order	order	O	O	O	O
that	that	O	O	O	O
this	this	O	O	O	O
syndrome	syndrome	O	O	O	O
might	might	O	O	O	O
be	be	O	O	O	O
investigated	investigated	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
mental	mental	O	O	O	O
status	status	O	O	O	O
(	(	O	O	O	O
M.S.	m.s.	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
correlated	correlated	O	O	O	O
with	with	O	O	O	O
serum	serum	O	O	O	O
concentrations	concentrations	O	O	O	O
and	and	O	O	O	O
renal	renal	O	O	O	O
and	and	O	O	O	O
hepatic	hepatic	O	O	O	O
function	function	O	O	O	O
in	in	O	O	O	O
36	36	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
30	30	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
no	no	O	O	O	O
M.S.	m.s.	O	O	O	O
change	change	O	O	O	O
on	on	O	O	O	O
cimetidine	cimetidine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
6	6	O	O	O	O
had	had	O	O	O	O
moderate	moderate	O	O	O	O
to	to	O	O	O	O
severe	severe	O	O	O	O
changes	changes	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
6	6	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
both	both	O	O	O	O
renal	renal	O	O	O	O
and	and	O	O	O	O
liver	liver	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
cimetidine	cimetidine	CHEMICALS	O	OTHERS	I
trough-concentrations	trough-concentrations	O	O	O	O
of	of	O	O	O	O
more	more	O	O	O	O
than	than	O	O	O	O
1.25	1.25	O	O	O	O
microgram/ml	microgram/ml	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
severity	severity	O	O	O	O
of	of	O	O	O	O
M.S.	m.s.	O	O	O	O
changes	changes	O	O	O	O
increased	increased	O	O	O	O
as	as	O	O	O	O
trough-concentrations	trough-concentrations	O	O	O	O
rose	rose	O	O	O	O
,	,	O	O	O	O
5	5	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
lumbar	lumbar	O	O	O	O
puncture	puncture	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
cerebrospinal	cerebrospinal	O	O	O	O
fluid	fluid	O	O	O	O
:	:	O	O	O	O
serum	serum	O	O	O	O
ratio	ratio	O	O	O	O
of	of	O	O	O	O
cimetidine	cimetidine	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
was	was	O	O	O	O
0.24:1	0.24:1	O	O	O	O
and	and	O	O	O	O
indicates	indicates	O	O	O	O
that	that	O	O	O	O
cimetidine	cimetidine	CHEMICALS	O	OTHERS	I
passes	passes	O	O	O	O
the	the	O	O	O	O
blood-brain	blood-brain	O	O	O	O
barrier	barrier	O	O	O	O
;	;	O	O	O	O
it	it	O	O	O	O
also	also	O	O	O	O
raises	raises	O	O	O	O
the	the	O	O	O	O
possibility	possibility	O	O	O	O
that	that	O	O	O	O
M.S.	m.s.	O	O	O	O
changes	changes	O	O	O	O
are	are	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
blockade	blockade	O	O	O	O
of	of	O	O	O	O
histamine	histamine	CHEMICALS	O	OTHERS	I
H2-receptors	h2-receptors	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
central	central	O	O	O	O
nervous	nervous	O	O	O	O
system	system	O	O	O	O
.	.	O	O	O	O

Patients	patients	O	O	O	O
likely	likely	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
both	both	O	O	O	O
raised	raised	O	O	O	O
trough-concentrations	trough-concentrations	O	O	O	O
and	and	O	O	O	O
mental	mental	O	O	O	O
confusion	confusion	O	DISEASE	OTHERS	I
are	are	O	O	O	O
those	those	O	O	O	O
with	with	O	O	O	O
both	both	O	O	O	O
severe	severe	O	O	O	O
renal	renal	O	O	O	O
and	and	O	O	O	O
hepatic	hepatic	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
.	.	O	O	O	O

They	they	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
closely	closely	O	O	O	O
observed	observed	O	O	O	O
and	and	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
given	given	O	O	O	O
reduced	reduced	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
cimetidine	cimetidine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

